[1] WOLF P. The Nature and Significance of Platelet Products in Human Plasma
[J]. British journal of haematology, 1967,13(3): 269-288.

[2] SAYED D, AMIN N F, GALAL G M. Monocyte-platelet aggregates and platelet micro-particles in patients with post-hepatitic liver cirrhosis
[J]. Thrombosis Research, 2010,125(5): e228-e233.

[3] 胡志清, 赵星鹏, 刘坦. 血小板微粒表面CD62p在缺血性脑卒中中的检测价值
[J]. 河南医学研究, 2021,30(33): 6298-6301.

[4] FREYSSINET J, TOTI F. Formation of procoagulant microparticles and properties
[J]. Thrombosis Research, 2010,125: S46-S48.

[5] HAGHBIN M, HASHEMI TAYER A, KAMRAVAN M, et al. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
[J]. Asian Pacific Journal of Cancer Prevention, 2021,22(5): 1573-1579.

[6] 李庆运, 曾俊玲, 陈煜森. 血小板微粒与缺血性脑卒中诊疗的研究进展
[J]. 海南医学, 2020,31(08): 1041-1045.

[7] 周蕾, 吴冬雨, 姚小梅, 等. 微粒体在缺血性卒中的作用
[J]. 中国卒中杂志, 2019,14(6): 619-624.

[8] LI J, GUAN X, FAN Z, et al. Non-Invasive Biomarkers for Early Detection of Breast Cancer
[J]. Cancers, 2020,12(10): 2767.

[9] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022
[J]. CA: a cancer journal for clinicians, 2022,72(1): 7-33.

[10] FATHI A T, BRAHMER J R. Chemotherapy for Advanced Stage Non-Small Cell Lung Cancer
[J]. Seminars in Thoracic and Cardiovascular Surgery, 2008,20(3): 210-216.

[11] LIU T, WANG J, LI T, et al. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles
[J]. BMC Cancer, 2021,21(1).

[12] LIU T, WANG J, LIU Y, et al. Prediction of the Therapeutic Effects of Pembrolizumab and Nivolumab in Advanced Non-Small Cell Lung Cancer by Platelet-Derived Microparticles in Circulating Blood
[J]. Technology in Cancer Research & Treatment, 2021,20: 1180463643.

[13] 刘利胜. 新化合物NEO212抗卵巢癌作用及其机制研究
[D]. 山东师范大学, 2021.

[14] LIU L, LI H, WANG N, et al. Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia
[J]. Hypertension Research, 2021,44(8): 996-1001.

[15] HU Q, WANG M, CHO M S, et al. Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
[J]. BBA Clinical, 2016,6: 76-81.

[16] MENAPACE L A, PETERSON D R, BERRY A, et al. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer
[J]. Thrombosis and haemostasis, 2011,106(2): 371.

[17] SINGH R, SOUSOU T, MOHILE S, et al. High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients
[J]. Journal of Thrombosis and Haemostasis, 2010,8(8): 1879-1881.

[18] IKEZOE T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies
[J]. International Journal of Hematology, 2021,113(1): 34-44.

[19] 戴益, 许玉玲, 刘莹, 等. 组织因子微粒、内皮细胞微粒及血小板微粒在急性髓细胞白血病中检测意义
[J]. 广西医科大学学报, 2022,39(05): 815-819.

[20] BALL S, NUGENT K. Microparticles in Hematological Malignancies: Role in Coagulopathy and Tumor Pathogenesis
[J]. Am J Med Sci, 2018,355(3): 207-214..